It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Dengue (DENV) and Zika (ZIKV) viruses are clinically important members of the Flaviviridae family with an 11 kb positive strand RNA genome that folds to enable virus function. Here, we perform structure and interaction mapping on four DENV and ZIKV strains inside virions and in infected cells. Comparative analysis of SHAPE reactivities across serotypes nominates potentially functional regions that are highly structured, conserved, and contain low synonymous mutation rates. Interaction mapping by SPLASH identifies many pair-wise interactions, 40% of which form alternative structures, suggesting extensive structural heterogeneity. Analysis of shared interactions between serotypes reveals a conserved macro-organization whereby interactions can be preserved at physical locations beyond sequence identities. We further observe that longer-range interactions are preferentially disrupted inside cells, and show the importance of new interactions in virus fitness. These findings deepen our understanding of Flavivirus genome organization and serve as a resource for designing therapeutics in targeting RNA viruses.
Here, the authors provide detailed analyses of viral RNA structure in virions and in infected cells for four dengue virus serotypes and four Zika virus strains, and identify conserved structures that are important for virus replication.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Bioinformatics Institute (A*STAR), Singapore, Singapore (GRID:grid.418325.9) (ISNI:0000 0000 9351 8132)
2 Genome Institute of Singapore, Stem Cell and Regenerative Biology, Singapore, Singapore (GRID:grid.418377.e) (ISNI:0000 0004 0620 715X)
3 Duke-NUS Graduate Medical School, Program in Emerging Infectious Diseases, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924)
4 Genome Institute of Singapore, Computational Biology, Singapore, Singapore (GRID:grid.418377.e) (ISNI:0000 0004 0620 715X)
5 National Neuroscience Institute, Department of Neurology, Singapore, Singapore (GRID:grid.276809.2) (ISNI:0000 0004 0636 696X); Genome Institute of Singapore, Stem Cell and Regenerative Biology, Singapore, Singapore (GRID:grid.418377.e) (ISNI:0000 0004 0620 715X)
6 National University of Singapore, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University of Singapore, Immunology programme, Life Sciences Institute, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
7 Genome Institute of Singapore, Infectious Diseases, Singapore, Singapore (GRID:grid.418377.e) (ISNI:0000 0004 0620 715X); London School of Hygiene & Tropical Medicine, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)
8 A*STAR, Institute of Materials Research and Engineering (IMRE), Singapore, Singapore (GRID:grid.185448.4) (ISNI:0000 0004 0637 0221); National University of Singapore, Department of Materials Science and Engineering, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
9 Genome Institute of Singapore, GERMS Platform, Singapore, Singapore (GRID:grid.418377.e) (ISNI:0000 0004 0620 715X)
10 Duke-NUS Graduate Medical School, Program in Emerging Infectious Diseases, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924); National University of Singapore, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University of Singapore, Saw Swee Hock School of Public Health, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
11 Duke-NUS Graduate Medical School, Program in Emerging Infectious Diseases, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924); National University of Singapore, Saw Swee Hock School of Public Health, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University of Singapore, Department of Pharmacy, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
12 Genome Institute of Singapore, Stem Cell and Regenerative Biology, Singapore, Singapore (GRID:grid.418377.e) (ISNI:0000 0004 0620 715X); Nanyang Technological University, School of Biological Sciences, Singapore, Singapore (GRID:grid.59025.3b) (ISNI:0000 0001 2224 0361); National University of Singapore, Department of Biochemistry, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)